Preparation, characterization and targeted delivery of serratiopeptidase immobilized on amino-functionalized magnetic nanoparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 85, Issue 3 PART A, 2013, Pages 413-426

  Kumar, Sandeep ^a   Jana, Asim K ^a   Dhamija, Isha ^b   Singla, Yashpaul ^c   Maiti, Mithu ^d  

^a DR B R AMBEDKAR NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b Guru Jambheswar University of Science and Technology   (India)

^c Lord Shiva Charitable Trust Sirsa   (India)

^d LOVELY PROFESSIONAL UNIVERSITY   (India)

Author keywords

Carrageenan induced paw oedema; Characterizations; Immobilization; Magnetic nanoparticles (MNPs); Serratiopeptidase; Target delivery

Indexed keywords

CARRAGEENAN; GLUTARALDEHYDE; MAGNETIC NANOPARTICLE; SERRATIOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; COVALENT BOND; CRYSTALLOGRAPHY; DRUG DELIVERY SYSTEM; ENZYME BINDING; ENZYME IMMOBILIZATION; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PAW EDEMA; RAT; THERMAL ANALYSIS; ZETA POTENTIAL;

CARRAGEENAN INDUCED PAW OEDEMA; CHARACTERIZATIONS; IMMOBILIZATION; MAGNETIC NANOPARTICLES (MNPS); SERRATIOPEPTIDASE; TARGET DELIVERY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EDEMA; GLUTARAL; INFLAMMATION; MAGNETICS; MAGNETITE NANOPARTICLES; MALE; PARTICLE SIZE; PEPTIDE HYDROLASES; RATS; RATS, WISTAR;

EID: 84888329718     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.06.019     Document Type: Article

References (63)

1. A. Panagariya, and A. Sharma A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome J. Assoc. Phys. India 47 1999 1170 1172
2. W. Kee, S. Tan, V. Lee, and Y. Salmon The treatment of breast engorgement with serrapeptase (Danzen): a randomised double-blind controlled trial Singapore Med. J. 30 1989 48 54
3. S. Nakamura, Y. Hashimoto, M. Mikami, E. Yamanaka, T. Soma, M. Hino, A. Azuma, and S. Kudoh Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease Respirology 8 2003 316 320
4. T.H. Al-Khateeb, and Y. Nusair Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars Int. J. Oral Maxillofac. Surg. 37 2008 264 268
5. C. Longhi, G.L. Scoarughi, F. Poggiali, A. Cellini, A. Carpentieri, L. Seganti, P. Pucci, A. Amoresano, P.S. Cocconcelli, M. Artini, J.W. Costerton, and L. Selan Protease treatment affects both invasion ability and biofilm formation in Listeria monocytogenes Microb. Pathog. 45 2008 45 52
6. A. Koyama, J. Mori, H. Tokuda, M. Waku, H. Anno, T. Katayama, K. Murakami, H. Komatsu, M. Hirata, and T. Arai Augmentation by serrapeptase of tissue permeation by cefotiam Jpn. J. Antibiot. 39 1986 761 771
7. M. Maheshwari, G. Miglani, A. Mali, A. Paradkar, S. Yamamura, and S. Kadam Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study AAPS PharmSciTech 7 2006 E162 E171
8. M. Rawat, S. Saraf, and S. Saraf Influence of Selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres AAPS PharmSciTech 8 2007 289 297
9. R.C. Pansuriya, and R.S. Singhal Effects of dissolved oxygen and agitation on production of serratiopeptidase by Serratia Marcescens NRRL B-23112 in stirred tank bioreactor and its kinetic modeling J. Microbiol. Biotechnol. 21 2011 430 437
10. G. Rath, E.S. Johal, and A.K. Goyal Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing Artif. Cells Blood Substit. Immobil. Biotechnol. 39 2011 44 50
11. S. Jadav, N. Patel, T. Shah, M. Gajera, H. Trivedi, and B. Shah Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats J. Pharmacol. Pharmacother. 1 2010 116 117
12. A. Mazzone, M. Catalan, and M. Costanzo Evaluation of serratiopeptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind, randomized trial versus placebo J. Int. Med. Res. 18 1990 379 388
13. S. Kv, G.S. Devi, and S.T. Mathew Liposomal formulations of serratiopeptidase: in vitro studies using PAMPA and caco-2 models Mol. Pharm. 5 2007 92 97
14. R.I. Mahato, A.S. Narang, L. Thoma, and D.D. Miller Emerging trends in oral delivery of peptide and protein drugs Crit. Rev. Ther. Drug Carrier Syst. 20 2003 153 214
15. V. Maximov, V. Reukov, and A.A. Vertegel Targeted delivery of therapeutic enzymes J. Drug Del. Sci. Technol. 19 2009 311 320
16. N. Nirale, and M. Menon Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation Indian J. Pharm. Sci. 72 2010 65 71
17. C.-C. Yu, Y.-Y. Kuo, C.-F. Liang, W.-T. Chien, H.-T. Wu, T.-C. Chang, F.-D. Jan, and C.-C. Lin Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis Bioconjug. Chem. 13 2012 714 724
18. T.P.N. Ngo, W. Zhang, W. Wang, and Z. Li Reversible clustering of magnetic nanobiocatalysts for high-performance biocatalysis and easy catalyst recycling Chem. Commun. 48 2012 4585 4587
19. K. Khoshnevisan, A.-K. Bordbar, D. Zare, D. Davoodi, M. Noruzi, M. Barkhi, and M. Tabatabaei Immobilization of cellulase enzyme on superparamagnetic nanoparticles and determination of its activity and stability Chem. Eng. J. 171 2011 669 673
20. 4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution Bioresour. Technol. 100 2009 3459 3464
21. Y. Ren, J. Rivera, L. He, H. Kulkarni, D.-K. Lee, and P. Messersmith Facile, high efficiency immobilization of lipase enzyme on magnetic iron oxide nanoparticles via a biomimetic coating BMC Biotechnol. 11 2011 63 70
22. Y. Jiang, C. Guo, H. Xia, I. Mahmood, C. Liu, and H. Liu Magnetic nanoparticles supported ionic liquids for lipase immobilization: enzyme activity in catalyzing esterification J. Mol. Catal. B Enzym. 58 2009 103 109
23. J.P. Chen, P.C. Yang, Y.H. Ma, and T. Wu Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator Carbohydr. Polym. 84 2011 364 372
24. E. Allard-Vannier, S. Cohen-Jonathan, J. Gautier, K. Herve-Aubert, E. Munnier, M. Souce, P. Legras, C. Passirani, and I. Chourpa Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo Eur. J. Pharm. Biopharm. 81 2012 498 505
25. O. Ziv-Polat, M. Topaz, T. Brosh, and S. Margel Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles Biomaterials 31 2010 741 747
26. S.H. Huang, M.H. Liao, and D.H. Chen Direct binding and characterization of lipase onto magnetic nanoparticles Biotechnol. Prog. 19 2003 1095 1100
27. 4-chitosan nanoparticles J. Mol. Catal. B Enzym. 61 2009 208 215
28. L. Ren, X. Wang, H. Wu, B. Shang, and J. Wang Conjugation of nattokinase and lumbrukinase with magnetic nanoparticles for the assay of their thrombolytic activities J. Mol. Catal. B Enzym. 62 2010 190 196
29. A. Petri-Fink, B. Steitz, A. Finka, J. Salaklang, and H. Hofmann Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies Eur. J. Pharm. Biopharm. 68 2008 129 137
30. N.A. Kalkan, S. Aksoy, E.A. Aksoy, and N. Hasirci Preparation of chitosan-coated magnetite nanoparticles and application for immobilization of laccase J. Appl. Polym. Sci. 123 2011 707 716
31. S. Liang, Y. Wang, J. Yu, C. Zhang, J. Xia, and D. Yin Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy J. Mater. Sci. Mater. Med. 18 2007 2297 2302
32. R. Kumar, B.S. Inbaraj, and B.H. Chen Surface modification of superparamagnetic iron nanoparticles with calcium salt of poly(γ-glutamic acid) as coating material Mater. Res. Bull. 45 2010 1603 1607
33. M. Faraji, Y. Yamini, and M. Rezaee Magnetic Nanoparticles: Synthesis, Stabilization, Functionalization, Characterization and Applications J. Iran. Chem. Soc. 7 2010 1 37
34. H. Kempe, and M. Kempe The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy Biomaterials 31 2010 9499 9510
35. E. Teodor, S.C. Litescu, V. Lazar, and R. Somoghi Hydrogel-magnetic nanoparticles with immobilized l-asparaginase for biomedical applications J. Mater. Sci.: Mater. Med. 20 2009 1307 1314
36. F. Bi, J. Zhang, Y. Su, Y.C. Tang, and J.N. Liu Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis Biomaterials 30 2009 5125 5130
37. V.e. Food Chemical Codex, Institute of Health, National Academy of Science, Washington, DC, vol. 2001, 2003, pp. 923-924.
38. L.N. Okassa, H. Marchais, L. Douziech-Eyrolles, K. Herve, S. Cohen-Jonathan, E. Munnier, M. Souce, C. Linassier, P. Dubois, and I. Chourpa Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles Eur. J. Pharm. Biopharm. 67 2007 31 38
39. S.-Y. Shaw, Y.-J. Chen, J.-J. Ou, and L. Ho Preparation and characterization ofPseudomonas putida esterase immobilized on magnetic nanoparticles Enzyme Microb. Technol. 39 2006 1089 1095
40. 4-chitosan nanoparticles J. Alloys Compd. 466 2008 451 456
41. S. Dandamudi, and R.B. Campbell The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting Biomaterials 28 2007 4673 4683
42. Y. Chen, and Y. Zhang Fluorescent quantification of amino groups on silica nanoparticle surfaces Anal. Bioanal. Chem. 399 2011 2503 2509
43. R.F.V. Lopez, J.H. Collett, and M.V.L.B. Bentley Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone Int. J. Pharm. 200 2000 127 132
44. I.J. Bosman, K. Ensing, and R.A. de Zeeuw Standardization procedure for thein vitro skin permeation of anticholinergics Int. J. Pharm. 169 1998 65 73
45. N. Peppas Analysis of Fickian and non-Fickian drug release from polymers Pharm. Acta Helv. 60 1985 110 111
46. J. Siepmann, and N.A. Peppas Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC) Adv. Drug Del. Rev. 48 2001 139 157
47. H. Sadeghi, V. Hajhashemi, M. Minaiyan, A. Movahedian, and A. Talebi A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats Eur. J. Pharmacol. 667 2011 396 401
48. G.-J. Huang, C.-H. Pan, F.-C. Liu, T.-S. Wu, and C.-H. Wu Anti-inflammatory effects of ethanolic extract of Antrodia salmonea in the lipopolysaccharide-stimulated RAW246.7 macrophages and the λ-carrageenan- induced paw edema model Food Chem. Toxicol. 50 2012 1485 1493
49. B. Hu, J. Pan, H.-L. Yu, J.-W. Liu, and J.-H. Xu Immobilization of serratia marcescens lipase onto amino-functionalized magnetic nanoparticles for repeated use in enzymatic synthesis of Diltiazem intermediate Process Biochem. 44 2009 1019 1024
50. G.K. Kouassi, J. Irudayaraj, and G. McCarty Examination of cholesterol oxidase attachment to magnetic nanoparticles J. Nanobiotechnol. 3 2005 < http://www.jnanobiotechnology.com/content/3/1/1 >
51. 4/amino-silane core-shell nanoparticles via layer-by-layer method Appl. Surf. Sci. 255 2009 7974 7980
52. M. Yamaura, R.L. Camilo, L.C. Sampaio, M.A. Macedo, M. Nakamura, and H.E. Toma Preparation and characterization of (3-aminopropyl)triethoxysilane-coated magnetite nanoparticles J. Magn. Magn. Mater. 279 2004 210 217
53. Y. Lin, Y. Wei, Y. Sun, and J. Wang Synthesis and magnetic characterization of magnetite obtained by monowavelength visible light irradiation Mater. Res. Bull. 47 2012 614 618
54. R.V. Branco, M.L.E. Gutarra, D.M.G. Freire, and R.V. Almeida Immobilization and characterization of a recombinant thermostable lipase (Pf2001) fromPyrococcus furiosus on supports with different degrees of hydrophobicity Enzyme Res. 2010 2010 180418
55. J. Zhu, and G. Sun Lipase immobilization on glutaraldehyde-activated nanofibrous membranes for improved enzyme stabilities and activities React. Funct. Polym. 72 2012 839 845
56. F. Xu, and H. Ding A new kinetic model for heterogeneous (or spatially confined) enzymatic catalysis: contributions from the fractal and jamming (overcrowding) effects Appl. Catal., A 317 2007 70 81
57. H. Zhu, J. Pan, B. Hu, H.-L. Yu, and J.-H. Xu Immobilization of glycolate oxidase from Medicago falcata on magnetic nanoparticles for application in biosynthesis of glyoxylic acid J. Mol. Catal. B Enzym. 61 2009 174 179
58. H. Xu, T. Song, X. Bao, and L. Hu Site-directed research of magnetic nanoparticles in magnetic drug targeting J. Magn. Magn. Mater. 293 2005 514 519
59. C. Vichasilp, K. Nakagawa, P. Sookwong, O. Higuchi, F. Kimura, and T. Miyazawa A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect Food Chem. 134 2012 1823 1830
60. R. Marroquin-Segura, M. Flores-Pimentel, R. Carreon-Sanchez, M.M. Garcia-Burciaga, J.L.A. Mora-Guevara, A. Aguilar-Contreras, and V.J. Hernandez-Abad The effect of the aqueous extract of Helietta parvifolia A. Gray (Rutaceae) stem bark on carrageenan-induced paw oedema and granuloma tissue formation in mice J. Ethnopharmacol. 124 2009 639 641
61. P. Crunkhorn, and S.C.R. Meacock Mediators of the inflammation induced in the rat paw by carrageenan Br. J. Pharmacol. 42 1971 392 402
62. R. Vinegar, W. Schreiber, and R. Hugo Biphasic development of carrageenan edema in rats J. Pharmacol. Exp. Ther. 166 1969 96 103
63. B. Chertok, A.E. David, and V.C. Yang Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography J. Control. Release 155 2011 393 399